Pediatrix Medical Group/$MD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Pediatrix Medical Group
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
Ticker
$MD
Sector
Health
Primary listing
NYSE
Employees
4,120
Headquarters
Website
MD Metrics
BasicAdvanced
$1.2B
11.19
$1.29
1.21
-
Price and volume
Market cap
$1.2B
Beta
1.21
52-week high
$17.67
52-week low
$9.50
Average daily volume
718K
Financial strength
Current ratio
1.798
Quick ratio
1.744
Long term debt to equity
73.622
Total debt to equity
77.908
Interest coverage (TTM)
5.59%
Profitability
EBITDA (TTM)
236.725
Gross margin (TTM)
24.36%
Net profit margin (TTM)
5.66%
Operating margin (TTM)
10.97%
Effective tax rate (TTM)
22.39%
Revenue per employee (TTM)
$470,000
Management effectiveness
Return on assets (TTM)
6.50%
Return on equity (TTM)
14.27%
Valuation
Price to earnings (TTM)
11.191
Price to revenue (TTM)
0.628
Price to book
1.48
Price to tangible book (TTM)
-2.95
Price to free cash flow (TTM)
5.366
Free cash flow yield (TTM)
18.64%
Free cash flow per share (TTM)
2.698
Growth
Revenue change (TTM)
-3.08%
Earnings per share change (TTM)
-142.49%
3-year revenue growth (CAGR)
-0.32%
10-year revenue growth (CAGR)
-2.86%
3-year earnings per share growth (CAGR)
9.81%
10-year earnings per share growth (CAGR)
-9.17%
What the Analysts think about MD
Analyst ratings (Buy, Hold, Sell) for Pediatrix Medical Group stock.
Bulls say / Bears say
Pediatrix Medical Group reported a 6.2% year-over-year increase in same-store sales for Q1 2025, indicating strong organic growth. (thepilotnews.com)
The company raised its full-year 2025 Adjusted EBITDA guidance to a range of $220 million to $240 million, reflecting confidence in its financial performance. (thepilotnews.com)
Pediatrix Medical Group's operating margin improved to 7% in Q1 2025, up from 3.2% in the same quarter last year, demonstrating enhanced operational efficiency. (thepilotnews.com)
Despite better-than-expected sales in Q1 2025, Pediatrix Medical Group's revenue declined by 7.4% year-over-year, raising concerns about overall growth. (thepilotnews.com)
The company reported a net loss of $99.07 million in 2024, a 64% increase from the previous year, indicating financial challenges. (stockanalysis.com)
Analysts have mixed opinions on Pediatrix Medical Group, with some maintaining a 'Sell' rating and setting a price target of $15.00, suggesting limited upside potential. (markets.businessinsider.com)
Data summarised monthly by Lightyear AI. Last updated on 10 Jul 2025.
MD Financial Performance
Revenues and expenses
MD Earnings Performance
Company profitability
MD News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Pediatrix Medical Group stock?
Pediatrix Medical Group (MD) has a market cap of $1.2B as of August 08, 2025.
What is the P/E ratio for Pediatrix Medical Group stock?
The price to earnings (P/E) ratio for Pediatrix Medical Group (MD) stock is 11.19 as of August 08, 2025.
Does Pediatrix Medical Group stock pay dividends?
No, Pediatrix Medical Group (MD) stock does not pay dividends to its shareholders as of August 08, 2025.
When is the next Pediatrix Medical Group dividend payment date?
Pediatrix Medical Group (MD) stock does not pay dividends to its shareholders.
What is the beta indicator for Pediatrix Medical Group?
Pediatrix Medical Group (MD) has a beta rating of 1.21. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.